Prescient Therapeutics (ASX:PTX) manufactures new range of binders for CAR-T cancer therapy
Prescient Therapeutics (PTX) has slipped on the ASX today despite announcing some key developments for...
Prescient Therapeutics (PTX) has slipped on the ASX today despite announcing some key developments for...
The terrible news this week that Tmunity Therapeutics, a clinical stage biotherapeutics company, has halted...
Australia’s medical community has welcomed a new ‘patent box’ tax regime designed to encourage further...
he federal government’s “patent box” initiative caught the eye of Australia’s biotech sector in Tuesday...
Prescient Therapeutics (ASX:PTX) has announced a new research program with the Peter MacCallum Cancer Centre...
Prescient Therapeutics Ltd (ASX:PTX) has signed an agreement related to advancing a new research program with...
Prescient Therapeutics (PTX) has announced a new research program with the Peter MacCallum Cancer Centre...
Biotech company Prescient Therapeutics (ASX:PTX) had an important announcement for the market this morning, after strengthening its...
Prescient Therapeutics has inked a new deal with leading research organisation Peter MacCallum Cancer Centre...
With the number of days left to file March quarterly reports running a little short...

This investor centre was built by Reach Markets
©2026 Reach Markets
To stay up to date with Prescient Therapeutics news and events, please register your details.